Interestingly, the distribution of dysplasia and adenocarcinoma in the WT and GPR4 KO AOM/DSS mice showed a 9% decrease in adenocarcinomas in the GPR4 KO mice compared with the WT mice (85% vs. 94%, respectively) (Figure 5E). Here, GPR4 is linked to adenocarcinoma.